FDA On Track To Meet MDUFMA Goals; Premarket Review Funding Gets Boost

摘要

FDA officials are giving an upbeat account of agency accomplishments during the first year of implementing the Medical Device User Fee and Modernization Act, while downplaying the impact of severe appropriations shortfalls and lower-than-expected user fee revenue.